West Pharmaceutical Services (WST) Total Liabilities (2009 - 2026)

West Pharmaceutical Services' Total Liabilities history runs 18 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Total Liabilities rose 19.71% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 19.71% YoY), while the FY2025 annual figure was $1.1 billion, up 13.83% from the prior year.
• Total Liabilities came in at $1.1 billion for Q1 2026 at West Pharmaceutical Services, up from $1.1 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $1.1 billion in Q1 2026 to a low of $846.0 million in Q3 2022.
• A 5-year average of $960.8 million and a median of $937.3 million in 2022 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities declined 10.03% in 2022 and rose 19.71% in 2026, its largest moves.
• West Pharmaceutical Services' Total Liabilities stood at $931.9 million in 2022, then grew by 1.78% to $948.5 million in 2023, then advanced by 1.33% to $961.1 million in 2024, then rose by 13.83% to $1.1 billion in 2025, then gained by 2.32% to $1.1 billion in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $1.1 billion, $1.1 billion, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison